Inari Medical Inc (NARI) - Aggregate Business Assets

NARI (Inari Medical Inc) - company brandmark

The competitiveness of Inari Medical, Inc. (NARI) is based on its ownership of unique patents in the field of thromboextraction and close cooperation with government procurement. Business efficiency is supported by a refined distribution system for sterile products through a network of regional hubs. The share price history demonstrates the overall trend, while total assets amount to 623.16, accompanied by the systematic upgrading of production capacities and the expansion of sterile workshops.

NARI (Inari) Company Total Assets history from 07/04/2022 to 03/01/2025

Financial and market metric breakdowns for Inari (NARI)

- current quotes and average value forecast:
Market Chart inarimedical.com|NARI - Consensus Target
- market capitalization indicators:
Market Value Inari Medical Corp|NARI - Enterprise Value
- balance sheet net asset value indicators:
Accounting Value of a Share Inari Medical|NARI - Book Capitalization|Market-to-Book Ratio inarimedical.com|NARI - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Inari Medical, Inc.|NARI - Long-Term Debt to Capital|Short-Term Debt to Capital Inari Medical Corp|NARI - Company Debts|Debts to Book Capitalization Ratio Inari Medical Corp|NARI - Company Long-Term Debts|Short-Term Debt Inari Medical
Basic company analysis:inarimedical.com NARI
Manufactured products of Inari

Total assets, reverse-calculated via ROA, determine the business's aggregate resource potential by combining equity and liabilities to evaluate asset utilization efficiency. An analysis of all company resources on the GURU.Markets platform demonstrates how the scale of the Inari Medical (NARI) asset base supports capital-intensive developments in catheter engineering, confirming the fundamental stability of this leader in minimally invasive thrombectomy.

Direct competitors

DXCM - Company Total Asset Base|Cumulative Company Assets PEN|NOVT (Novanta Inc) - Aggregate Business Assets|Company Total Assets HAE|INSP (Inspire Medical Systems Inc) - Aggregate Asset Value|Company Total Assets PRCT (PROCEPT BioRobotics)|conmed.com (CNMD) - Company Assets|PLSE - Aggregate Company Assets|Aggregate Asset Value INMD (InMode Ltd)|PMI: Company Total Assets|Surmodics Inc. (SRDX) - Company Total Assets|Aggregate Company Assets Senseonics Holdings Inc|neuropace.com - Total Asset Value of Company|Company Total Assets TCMD|SNWV - Company Assets|Outset - Cumulative Company Assets|Company Total Assets SmartVest ELMD|LNSR: Cumulative Company Assets|avitamedical.com - Aggregate Business Assets|PROF: Company Total Assets|BDMD - Company Total Asset Base|EDAP (EDAP TMS SA) - Company Total Assets|Cumulative Company Assets Bovie Medical (APYX)|Cumulative Company Assets ICCM (IceCure Medical Ltd)|LUNG (pulmonx.com) - Aggregate Asset Value|Aggregate Company Assets TELA Bio TELA|CTSO - Cumulative Company Assets|Sensus Healthcare Corp - Company Total Assets|Company Assets Zynex Corp|ECOR: Company Total Assets|Total Business Assets RBOT|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Company Total Assets|SeaStar Medical Holding Corporation (ICU) - Company Total Asset Base|Company Total Assets IRIX|Cumulative Company Assets ibs.inc INBS|Company Total Assets XAIR (Beyond Air)|Company Total Assets profusa.com PFSA|SSKN - Aggregate Company Assets|GCTK: Aggregate Company Assets|NAOV (NanoVibronix) - Cumulative Company Assets|Venus Concept Corporation - Aggregate Asset Value|NUWE (Nuwellis, Inc.) - Company Total Assets|Company Assets aethlonmedical.com AEMD|Aggregate Company Assets Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Company Balance Sheet Assets|BioSig Technologies, Inc. - Cumulative Company Assets|Company Total Assets Cutera Inc CUTR|Know Labs, Inc. - Company Total Assets|Company Total Asset Base nevro.com NVRO|reshapelifesciences.com (RSLS) - Aggregate Company Assets|Total Asset Value of Company SILK (Silk Road Medical, Inc.)